| |
| |
|
| Insider
Information: |
Stejbach Mark |
| Relationship: |
Director |
| City: |
East Norriton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
79,728 |
|
|
Indirect Shares
|
1,580 |
|
|
| Direct
Value |
$1,226,581 |
|
|
|
Indirect Value
|
$14,410 |
|
|
| Total
Shares |
81,308 |
|
|
| Total
Value |
$1,240,991 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.8%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tengion Inc |
TNGN |
VP and Chief Commercia... |
2011-05-11 |
28,663 |
2010-04-09 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
SVP/Chief Comm Off, Al... |
2018-03-03 |
51,065 |
|
0 |
Premium* |
|
|
Flexion Therapeutics Inc |
FLXN |
Director |
2021-11-19 |
0 |
2020-06-10 |
1,580 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Chief Commercial OfficerOffice |
• – – |
2012-02-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
200 |
|
- |
|
| TNGN |
Tengion Inc |
VP & Chief Commercial Officer |
• – – |
2010-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,896 |
1,996 |
0 |
- |
|
| TNGN |
Tengion Inc |
VP and Chief Commercial Offcr |
• – – |
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
26,667 |
28,663 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2014-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,680 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
11,678 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
17,453 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
21,640 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Chief Commercial Officer |
• • – |
2015-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
19,564 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2016-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
22,189 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2016-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
24,150 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2016-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
26,650 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2016-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
31,650 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
36,740 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
41,138 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,812 |
41,513 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
44,013 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
47,013 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,250 |
51,837 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2018-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,813 |
52,316 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
6,551 |
0 |
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
12,631 |
0 |
- |
|
| TNGN |
Tengion Inc |
VP & Chief Commercial Officer |
• – – |
2010-04-09 |
4 |
B |
$5.00 |
$500 |
D/D |
100 |
100 |
2.66 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-01-05 |
4 |
OE |
$17.30 |
$5,190 |
D/D |
300 |
34,415 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-01-09 |
4 |
OE |
$17.30 |
$9,463 |
D/D |
547 |
34,662 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP/Chief Comm Off, Alks Inc |
• • – |
2017-01-05 |
4 |
AS |
$60.09 |
$18,026 |
D/D |
(300) |
34,115 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
